chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient stated that she has a rash in al over her body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Patient stated that she has a rash in al over her body) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Patient stated that she has a rash in al over her body). At the time of the report, RASH (Patient stated that she has a rash in al over her body) had not resolved.            No Concomitant product use was reported. No treatment information was provided.  The patient stated that they got the booster dose and had a rash in all over their body.   This case was linked to MOD-2021-417079 (Patient Link).
Moderna COVID-19 Vaccine EUA tingling and numbness in the mouth, tongue, & throat
Patient loss consciousness upon administering vaccine, regain after 10-15 sec. responded to question. BP 99/55, called 911-EMT said pt. is ok to go home. BP normal 115/77.
On Sunday morning July 14th I woke up w/  L upper arm itching redness and an approx 3  inch circ well defined hive . I treated it with topical aloe and 1-2 x topical Hydrocortisone. The hive decreased after day one. The itching  lasted for several days. All sx are now resolved.
Patient experienced pain and significant swelling starting within 24 hours of receiving vaccine. Swelling improved, within two days, but pain has remained and range of motion is compromised after 4 days.
Got a slightly raised, itchy patch in area of injection site. Felt like a mosquito bite. Area was slightly hard to the touch. No pain.
Early afternoon on 10/22/2021 following vaccine - fatigue, chills, headache; later that evening - fatigue, severe chills, severe body aches, headache, fever over 101.8; symptoms lasted through the night and fever broke around 6:00am on 10/23/2021; body aches, headache and fatigue improved through 10/24/2021 10/25/2021 - noticed a feeling of minor congestion/inflammation/swelling deep in sinuses, unable to productively blow nose to clear congestion; headaches persisted to varying degrees, feeling mostly sinus-related; tried Sudafed and Claritin in attempt to clear congestion/feeling of swollen or inflamed sinuses and nothing worked - feeling of swollen/inflamed sinuses persisted 11/20/2021 upon waking at approximately 5:20am - began smelling smoke like an acrid campfire and had accompanying headache; previous experience with sinus infections started with the olfactory hallucination of a smoke smell and occasional smoke taste in the back of my throat; took Sudafed and Excedrin with headache improving but sinus congestion/inflammation did not improve; added saline nasal spray to clear sinuses with no success 11/22/2021 at 10:00 - made appointment with primary care provider  NP unavailable so saw another NP in the office) and was diagnosed with a sinus infection
My husband has a head cold after all the vaccines he received; This spontaneous case was reported by a non-health professional and describes the occurrence of NASOPHARYNGITIS (My husband has a head cold after all the vaccines he received) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (My husband has a head cold after all the vaccines he received). The patient was treated with ATORVASTATIN at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (My husband has a head cold after all the vaccines he received) outcome was unknown.            Concomitant medications were not reported. Patient had a head cold after all the vaccines he received. That was a typical symptom of the vaccines Reporter confirmed that they only received all six doses of Moderna COVID-19 vaccines.   This case was linked to MOD-2023-732936 (Patient Link).
5/5 ER-fever/chills-c/o general body aches-started last week and during injections for hepatitis-159/107-98.22-99.5. (Received Hep A/Hep B/ Tetanus) c/o diarrhea/general malaise (admit dx: post serum sickness, dehydration) WBC 8.1. 5/7 pt transferred to hospital. Diagnosis is diverticulitis with abscess.
Faint sweaty   99/47   Bp 120/84  pulse 52  4 l o2 97%
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 51-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of injection site pain (For tolerability of the first dose of SHINGRIX, refer case US2019GSK027933). On 6th February 2019, the patient received the 2nd dose of SHINGRIX. On an unknown date, the dose was an unknown dose. In February 2019, less than a week after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the patient experienced product supply issue. On an unknown date, the outcome of the injection site pain was not recovered/not resolved and the outcome of the product supply issue was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient's wife reported that her husband received the 1st dose of SHINGRIX last year and approximately 1 year later, received the 2nd dose. The reporter stated that the patient was not able to get the 2nd dose within 6 months due to the shortage. The patient experienced soreness at the injection site. The soreness from the 2nd dose had not subsided till the time of reporting. There was some by the pharmacist thinking that the patient would have to start the series again since it was too long since he had the first shot but later it was cleared and they confirmed that it was not necessary.
This spontaneous report as received from a health care worker refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with a 0.5 milliliter (ml) of an improperly stored VAQTA (lot number H010437 and expiry date 28-FEB-2015) on the left thigh intramuscularly. No concomitant medications were reported. No adverse effects reported. Additional information has been requested.
Information has been received from a physician concerning a male who was vaccinated IM with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine. The physician reported that, three days after being vaccinated, the pt's arm became swollen, red, warm to the touch and tender. Unspecified medical attention was sought, but no prescription drug treatment was required and laboratory/diagnostic tests were performed. Subsequently, the pt's event abated. Additional information has been requested.
They had a fever but only after taking the covid shot; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NVSC2020US016115 (Norvatitis).  A 53-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "They had a fever but only after taking the covid shot". Relevant laboratory tests and procedures are available in the appropriate section.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a female patient who received Shingrix for prophylaxis. On 4th April 2018, the patient received the 1st dose of Shingrix. On 4th April 2018, less than a day after receiving Shingrix, the patient experienced injection site erythema, general body pain, fever, injection site swelling, injection site warmth and rash. On an unknown date, the outcome of the injection site erythema, general body pain, fever, injection site swelling and injection site warmth were recovered/resolved and the outcome of the rash was unknown. It was unknown if the reporter considered the injection site erythema, general body pain, fever, injection site swelling, injection site warmth and rash to be related to Shingrix. Additional details were received as follows: The age at vaccination was not reported. The patient received Shingrix on the left arm. On the day of vaccination, at night, the patient started to experience all the symptoms. The injection site became red, swollen and hot to touch with a rash that went down half of her arm. The patient had a fever and body aches. The redness lasted over a week. The swelling and hotness lasted 8 to 10 days and the body aches lasted for 5 days. The patient denied permission to contact their physician.
Stomach cramps; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramps) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Stomach cramps) (seriousness criterion medically significant). At the time of the report, ABDOMINAL PAIN UPPER (Stomach cramps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported.   The treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Event was classified as serious by regulatory authority (seriousness criteria: medically important condition). However, as per medical criteria the event was not serious (not medical event listed).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Event was classified as serious by regulatory authority (seriousness criteria: medically important condition). However, as per medical criteria the event was not serious (not medical event listed).
This spontaneous case reported by a consumer, describes the occurrence of COVID-19 (tested positive for COVID) and anosmia (loss of smell) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 030L20A) for COVID-19 vaccination. No medical history reported. On Feb 20, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 15, 2021, patient experienced COVID-19 (tested positive for COVID). On an unknown date, patient experienced anosmia (loss of smell). At the time of the report, COVID-19 (tested positive for COVID) and anosmia (loss of smell) outcome: unknown. Diagnostic results: On Mar 15, 2021, SARS-CoV-2 test: positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant information or treatment information reported.
near syncope 10min p/inj;residual dizziness x 1hr;happened @ work place;911 eval & sent to ER;no abnormalities found;released-cause of near syncope undetermined;
About two weeks after being vaccinated I starting having, and continue to have, frequent menstrual spotting. My mood has been adversely affected. I am depressed, with no motivation and diminished sex drive. This is very unlike me and has negatively impacted my mental health and relationship with my husband.
CAN HEAR OWN HEART BEAT IN EARS; BODY ACHES SORENESS; CHILLS; NOT STRONG WEAK; HEADACHE; .This spontaneous report received from a patient concerned a 23 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 27-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 27-APR-2021, the subject experienced can hear own heart beat in ears. On 27-APR-2021, the subject experienced body aches soreness. On 27-APR-2021, the subject experienced chills. On 27-APR-2021, the subject experienced not strong weak. On 27-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, headache, not strong weak, body aches soreness and can hear own heart beat in ears was not reported. This report was non-serious.
Initial and follow up information has been received from a healthcare worker concerning a 70 year old retired female patient with no reported medical history who on 12/2/04 was vaccinated in the left deltoid (route not reported) with a second dose of pneumococcal 23v polysaccharide vaccine (lot # 649914/0578P). Concomitant medications include lansoprazole, salcatonin, and lorazepam. Approximately two day post vaccination, the patient developed nausea and a cellulitis type reaction at the injection site with warmth, redness, pain and low grade fever. The reporter confirmed that the patient was treated with cefditoren pivoxil 2 time daily for 7 days and promethazine hydrochloride as needed for nausea. The reporter also confirmed that the patient's experienced was considered serious. It was also reported that the patient recovered on 12/15/04. The patient's experience with injection site cellulitis, low grade fever, nausea and pain, that required medical intervention, was considered to be an important medical event (OMIC). The healthcare worker reported that that patient received her first dose of pneumococcal 23v polysaccharide vaccine on 10/14/96. There was no product quality complaint involved. It was also reported that 3 other adult female patients experienced the same adverse event following administration of pneumococcal 23v polysaccharide vaccine (lot # 649914/0578P) (WAES0412USA00679, 0501USA00531, and 0501USA00532). Additional information is not expected.
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medication and drug reactions/allergies were not provided. On 07-DEC-2018, the patient was inadvertently administered a dose of PROQUAD (lot # R015738, expiration date 02-DEC-2019; strength and dose were not provided) that was reconstituted with sterile diluent by intramuscular rather than subcutaneous (incorrect route of product administration) for prophylaxis. No adverse effect reported.
Pt received Tdap (LA) and Menactra Vacccines (RA) on 8/8/06.  On 8/9/06 she developed left wrist pain that evolved into B/L wrist pain and hand pain by 8/10.  Pt was unable to use hands due to pain on 8/11-8/13.  Movement of hands caused sig pains.  Ice helped to relieve symptoms.     By evening of 8/12 hand and wrist pain resolved and knee and upper arm pain emerged.  On 8/13 pt described sig pains on moving her upper arms a certain way and a general dull ache otherwise.  Pt also limped at that time due to knee pains. Today (8/14) patients symptoms have begun resolving though upper arm pain and knee pains persist. 01/30/07-records received and reviewed. DOS 8/14/06-patient with history of left wrist pain on 8/9/07 day after vaccination. On 8/10 fingers hurt bilaterally. Then over weekend developed knee pains. Arm pain started Sunday night, hands felt swollen over weekend and it hurt to use her hands. Moving them caused shooting pains. Now has moving pain. On 8/14/07 feeling in arms and hands better without fevers. Slight rash in shot where vaccine was administered. Strength WNL. Reflexes normal. Impression: Acute neuropathy. 8/22/06 patient symptoms resolved by August 16, 2006. To college.
This spontaneous report as received from a healthcare worker refers to a 4 year old patient of unknown gender. The patient's concurrent conditions and medical history were not reported. On 03-AUG-2015, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (lot number L005297 and expiration date 23-SEP-2016, dose and route of administration were not provided). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter (Other HCP). The reporter is the patient.  A 31-year-old female patient (pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient had no known allergies. The patient was 20 weeks pregnant at the event onset. The patient is expected to deliver a baby(s) on 27Nov2022. Concomitant medication(s) included: SERTRALINE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Anti-viral drug Paxlovid.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the available information and known product profile, the causal relationship of the reported drug ineffective and the use of BNT162B2 cannot be fully excluded.
Pt given shingles vaccination at pharmacy on 8/15/14 in (R) arm - developed induration and bruising in the arm locally w/in 24 hours. In 1-2 days developed (R) Bell's palsy.
Initial report received from a healthcare professional on 16 October 2013. A male patient whose age at the time of event, medical history and concomitant medication were not reported, had received a dose of PENTACEL (dose number, lot number, route of administration were not reported) in the leg on 04 August 2013. On an unspecified date, upon receiving PENTACEL, the patient froze for 30 seconds, had a scaring episode and child's eyes were dilated. Laboratory investigations and corrective medications were not reported. At the time of this report, the outcome was unknown. Documents held by sender: None.
Chest Pain      x2 days, heaviness     HPI Pt states URI type symptoms for the past 2 days. Runny nose; fever, chills, feeling tired.  Fatigued with chest heaviness and tired. No exertional dyspnea; no chest pain. No SOB. No nausea or vomiting. States thought it was covid and took a test a few days ago but it was negative.  Review of Systems  Constitutional: Positive for chills, fatigue and fever.  HENT: Positive for congestion and rhinorrhea.   Cardiovascular: Negative for chest pain, palpitations and leg swelling.  Musculoskeletal: Positive for myalgias.  All other systems reviewed and are negative.
Covid vaccine administered on right deltoid at 3:03 pm. Tdap vaccine administered on left deltoid at 3:04 pm. Patient had a fainting episode at 3:05 pm, right after Tdap vaccine was administered. Patient began syncope episode and then became stiff and had a tremor episode lasting for about 30 seconds. Vital signs taken right away. Blood pressure 134/90, Heart rate: 104, Oxygen Saturation: 100%, Temperature: 99.2, Respirations 32.  Patient was examined by Dr. Blood pressure was taken again at 3:11 pm, reading 125/88, Heart rate: 82 Oxygen Saturation: 100%
Patient said she started feeling numb and tingly on her left side. It started on her arm and she said it traveled down her left side and down her leg.  She said it started just a few minutes after it was administered.
dizziness; This is a spontaneous report from a contactable consumer (patient).  A 64-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: UL9762 and expiration date not provided), via an unspecified route of administration, administered in Arm Right on 16Feb2021 12:30 as 2ND DOSE, SINGLE for covid-19 immunisation. The patient's medical history included psoriasis, psoriatic arthritis, hypertension, and high cholesterol. The patient's concomitant medications included losartan, indapamide, rosuvastatin, and finasteride.  The patient previously took Cipro and experienced allergy. The patient historical vaccine includes bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN5318) administered in in Left arm first dose on 27Jan2021. On 19Feb2021, the patient experienced dizziness. No treatment was given for the event. The outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
Pt recvd 2 doses of Engerix-B & soon p/2nd dose exp swelling & itching of eyes, ears, palms, soles of feet (no rash); these sx resolved;
Headache, Arthralgia, ErythemaMultiform, UrticariaPruritus, NauseaVomiting, fatigue, chills, injection site eating Narrative:
Nausea and stomach pains began at 4:00pm, followed by vomiting starting at 4:45 pm., repeatedly, to the point of dry heaves through 12/06/09 at 2am.  Could not keep even the smallest amount of water or watered down gatorade.
With my chronic fatigue syndrome (cause never able to be diagnosed) I always feel run down and sleep is unrefreshing.  Kind of like when someone has a minor cold.  After the first shot I felt more fatigued but still functional.  After the second shot, however, I got quite sick with an immune reaction by the next day.  The fever went away, but the fatigue has turned to absolute lethargy that has never gone away.  Unless I am stimulated by something, I cannot stay awake.  When I try to do my job, which involves extensive typing all day, I keep falling asleep and have to start over and/or recheck all my work.  I am hemorrhaging money due to this (I get paid by the amount of work I do, not by the hour) and struggling to pay my bills.  I felt like I had a gun to my head to get this shot since I have been trying to find a more stable hourly job, but I regret it so much now as I feel horrible and struggle to stay awake every day for more than a month now.  I have NEVER had anything like this with my chronic fatigue syndrome.  I've felt run down chronically, yes, but I have never struggled to stay awake all day every day the second I am not being stimulated (i.e. I can drive just fine, but the second I sit down and try to do anything boring and repetitive, I'm constantly nodding off and waking up when I start to fall over in my chair).  This is extremely scary, frustrating, and financially destroying me.
about two weeks after vaccine, began experiencing ear ringing/buzzing (loud and non-stop).  Also, developed shingles like rash on right side of head/right ear.  This shingles like rash then proceeded to go on face and up over forehead and to the left side of my head/ear.  The doctor prescribed steroids to help with the "shingles".  The ear ringing/buzzing has continued for months and still is a major issue in April of 2022.